Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

RNA Splicing01:32

RNA Splicing

60.6K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

25.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.1K
No description available
5.1K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Chromatin Structure and RNA Splicing02:41

Chromatin Structure and RNA Splicing

3.4K
No description available
3.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

735
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
735

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.

Skeletal muscle·2026
Same author

Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Quantitative tandem mass tag-based serum proteomics for longitudinal biomarker monitoring in Duchenne muscular dystrophy.

Clinical proteomics·2026
Same author

MDBiomarkers: A queryable biomarkers database integrating multiple serum and tissue datasets for Duchenne muscular dystrophy.

Journal of neuromuscular diseases·2026
Same author

Guidance on communication and informed consent with patients and their families for experimental individualized treatments.

American journal of human genetics·2026
Same author

Paying for precision: funding approaches for N-of-1 trials of individualized gene targeted therapies.

Orphanet journal of rare diseases·2026

Video Experimental Relacionado

Updated: Jan 31, 2026

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.8K

Terapias moduladoras de empalme para enfermedades humanas.

Pietro Spitali1, Annemieke Aartsma-Rus

  • 1Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Cell
|March 20, 2012
PubMed
Resumen

La desregulación del empalme, un proceso que altera la expresión génica, causa muchas enfermedades. Están surgiendo estrategias terapéuticas para corregir errores de empalme, ofreciendo nuevas posibilidades de tratamiento para afecciones genéticas y adquiridas.

Más Videos Relacionados

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.4K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K

Videos de Experimentos Relacionados

Last Updated: Jan 31, 2026

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.8K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.4K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K

Área de la Ciencia:

  • Biología Molecular Biología Molecular
  • Genética La genética.
  • Las terapias terapéuticas.

Sus antecedentes:

  • El empalme y el empalme alternativo son procesos cruciales de expresión génica.
  • La desregulación de estos procesos está implicada en numerosas enfermedades genéticas y adquiridas.
  • El empalme dirigido ofrece una vía terapéutica prometedora.

Objetivo del estudio:

  • Proporcionar una visión general de las estrategias terapéuticas recientes para modular el empalme.
  • Para resaltar los éxitos en contextos clínicos y preclínicos.
  • Discutir enfoques para la generación de proteínas beneficiosas y la eliminación de las nocivas mediante el empalme.

Principales métodos:

  • Revisión de la literatura reciente sobre las terapias de modulación de empalme.
  • Análisis de los datos clínicos y preclínicos.
  • Categoría de estrategias terapéuticas basadas en su mecanismo de acción.

Principales resultados:

  • Varias estrategias modulan eficazmente el empalme de manera terapéutica.
  • Los enfoques incluyen restaurar marcos de lectura abiertos, influir en el empalme alternativo e inducir la inclusión de exones.
  • Estos métodos tienen como objetivo producir proteínas funcionales o eliminar las dañinas.

Conclusiones:

  • La modulación de empalme terapéutico es un campo que avanza rápidamente.
  • Las estrategias exitosas se están traduciendo a entornos clínicos y preclínicos.
  • El empalme dirigido tiene un potencial significativo para el tratamiento de una amplia gama de enfermedades.